Saint Lucia vs Suriname: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Saint Lucia
0.2%
in 2024
Suriname
0.2%
in 2024
Saint Lucia rank
78th
Suriname rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Saint Lucia
- Suriname
How they compare
Saint Lucia currently reports 0.2% against 0.2% in Suriname, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Saint Lucia ahead.
Saint Lucia ranks 78th and Suriname ranks 78th of 215 countries.
Saint Lucia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Lucia | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.1% | Saint Lucia |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Saint Lucia or Suriname?
- Saint Lucia, at 0.2% against 0.2% in Suriname as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Saint Lucia and Suriname?
- 0.0%, with Saint Lucia ahead.
- How many years of comparable data are there for Saint Lucia and Suriname?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Lucia and Suriname rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Saint Lucia ranks 78th and Suriname ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.